149 related articles for article (PubMed ID: 3903552)
1. Comparison of a CEA-EIA assay based on monoclonal antibody with a CEA-RIA assay with polyclonal antiserum.
Orjasaeter H; Staab HJ; Heier HE; Hornung A; Kjørstad K; Luedin E; Rognum TO; Bell H
NIPH Ann; 1985 Jun; 8(1):13-26. PubMed ID: 3903552
[TBL] [Abstract][Full Text] [Related]
2. EIA versus RIA in detecting carcinoembryonic antigen level of patients with metastatic colorectal cancer.
Wang WS; Lin JK; Lin TC; Chiou TJ; Liu JH; Yen CC; Chen WS; Jiang JK; Yang SH; Wang HS; Chen PM
Hepatogastroenterology; 2004; 51(55):136-41. PubMed ID: 15011849
[TBL] [Abstract][Full Text] [Related]
3. [Studies on serum CEA levels measured by enzyme immunoassay using monoclonal CEA-antibodies].
Takada S; Hoshi H; Ito F; Imai K; Yachi A
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1487-91. PubMed ID: 6378102
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
Klech H; Rona G; Hutter C; Bayer PM; Kummer F
Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies against carcinoembryonic antigen (CEA) used in a solid-phase enzyme immunoassay. First clinical results.
Buchegger F; Phan M; Rivier D; Carrel S; Accolla RS; Mach JP
J Immunol Methods; 1982 Mar; 49(2):129-39. PubMed ID: 7040549
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Ca 12-5 as a tumor marker for gastric and colo-rectal cancer in comparison to CEA and Ca 19-9.
Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
Eur J Surg Oncol; 1987 Jun; 13(3):197-201. PubMed ID: 3474158
[TBL] [Abstract][Full Text] [Related]
7. [Enzyme immunoassay of CEA using monoclonal antibody].
Arai K; Kanikawa S; Isomura M; Takemori Y; Kanda Y; Ishii M
Gan To Kagaku Ryoho; 1982 Dec; 9(12):2161-7. PubMed ID: 6764098
[TBL] [Abstract][Full Text] [Related]
8. [Advantages and limitations of combined assays of 4 serum markers in various types of malignant neoplasms].
Lanza E; Coda C; Ramella S; Ciambellotti E; Moro G; Cartia GL
Minerva Med; 1986 Sep; 77(34-35):1521-5. PubMed ID: 3463886
[TBL] [Abstract][Full Text] [Related]
9. CEA and NCA levels in peripheral and tumour venous blood of patients with gastric and colonic carcinomas estimated by RIA and EIA methods.
Harłozińska A; Rachel F; Gawlikowski W; Richter R; Kołodziej J
Eur J Surg Oncol; 1991 Feb; 17(1):59-64. PubMed ID: 1995360
[TBL] [Abstract][Full Text] [Related]
10. [Basic and clinical studies on serum CEA levels using a new CEA-EIA (double monoclonal) kit].
Ogoshi K; Mitomi T
Gan No Rinsho; 1984 Dec; 30(15):1913-8. PubMed ID: 6396422
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody CIBCHTB1 defining an epitope on carcinoembryonic antigen (CEA).
Meenakshi A; Kumar NS; Vijayshanker SG
Hum Antibodies; 2000; 9(4):223-9. PubMed ID: 11341176
[TBL] [Abstract][Full Text] [Related]
12. [Comparison between stool CEA and serum CEA in colorectal cancer measured by monoclonal anti-CEA antibody].
Ishii K; Takemura K; Endo M
Nihon Geka Gakkai Zasshi; 1985 Aug; 86(8):972. PubMed ID: 3903470
[No Abstract] [Full Text] [Related]
13. [Clinical significance of serum CEA determination in the diagnosis of colo-rectal cancer].
Jiang R
Zhonghua Zhong Liu Za Zhi; 1989 Sep; 11(5):348-51. PubMed ID: 2620629
[TBL] [Abstract][Full Text] [Related]
14. Determination of carcinoembryonic antigen (CEA): comparison of two different assays.
Orjasaeter H
Acta Pathol Microbiol Scand C; 1978 Dec; 86C(6):265-75. PubMed ID: 726896
[TBL] [Abstract][Full Text] [Related]
15. Methodological and clinical evaluation of two automated enzymatic immunoassays as compared with a radioimmunoassay for neuron-specific enolase.
Schmitt UM; Stieber P; Hasholzner U; Pahl H; Hofmann K; Fateh-Moghadam A
Eur J Clin Chem Clin Biochem; 1996 Aug; 34(8):679-82. PubMed ID: 8877347
[TBL] [Abstract][Full Text] [Related]
16. [Enzyme immunoassay and radioimmunoassay using monoclonal antibody for the determination of estrogen receptors in human breast cancer].
Ohnami S; Nakayama C; Ohnami S; Zeze F; Eto S
Gan To Kagaku Ryoho; 1986 Dec; 13(12):3447-52. PubMed ID: 3539025
[TBL] [Abstract][Full Text] [Related]
17. [Clinical application of carcinoembryonic antigen (CEA) monoclonal antibodies (McAbs)].
Cheng M; Yin HZ; Feng XQ
Zhonghua Zhong Liu Za Zhi; 1987 Jan; 9(1):14-6. PubMed ID: 3297586
[TBL] [Abstract][Full Text] [Related]
18. The biological and clinical significance of tumor markers in tissue extracts.
Castelli M; Sega FM; Sciarretta F; Casale V; Coloni F; Sega E
Cancer Detect Prev; 1983; 6(1-2):61-6. PubMed ID: 6883394
[TBL] [Abstract][Full Text] [Related]
19. [Clinical evaluation of a new tumor marker, CA 15-3, in breast cancer; a comparative study with CEA].
Komuro K; Watanabe K; Ishida T; Sakurai M; Amano R; Hagiwara H; Hara Y; Hanzawa T; Itsubo K
Gan To Kagaku Ryoho; 1986 Oct; 13(11):3145-9. PubMed ID: 3465273
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of dot-immunobinding assay for carcinoembryonic antigen determination in nipple discharge as an adjunct in the diagnosis of early breast cancer. Research Group for Carcinoembryonic Antigen in Nipple Discharge.
Mori T; Inaji H; Higashiyama M; Yayoi E; Izuo M; Ueno E; Enomoto K; Kasumi F; Sakamoto G; Tominaga T
Jpn J Clin Oncol; 1989 Dec; 19(4):373-9. PubMed ID: 2691732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
